Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.

By O. Hermine, X. Mariette, P. Tharaux, M. Resche-Rigon, R. Porcher, Philippe Ravaud. JAMA Internal Medicine, 2020

716 citations recorded by the source corpus.

Subfields: Infectious Diseases, Neurology

View Paper: https://www.semanticscholar.org/paper/b18e5f82b13f429664020655a0607ab28bceeaa2

Citations in the corpus

• Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 (2021, neutral): “9) (n=815) APACHE II score e - median (IQR) 13 (8-19) (n=337) 10 (7-16) (n=42) 12 (8-18) (n=381) 12.”